News
News Update
Business Wire
Press Releases
Economy
Business Life
Opinion
Legal Center
Classifieds
Executive Calendar
Networking Calendar
Subscribe
Archives
Contact Us
Links
Media Kit
Home



Press Releases
Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting
New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy
Orbis FEH Program in Trujillo, Peru Receives Visit from OMEGA Brand Ambassador Cindy Crawford
ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines
Transparency Life Sciences To Conduct Sarcoidosis Trial For Auven Therapeutics' Kiacta™ Using Crowdsourcing And Telemonitoring
Blood Pressure Treatment Benefits on Survival Persist for Years - New Findings in Patients with Type 2 Diabetes
PharmaBoardroom Releases New Spain Pharmaceuticals Report
EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time
Low T Center Endorses The Joint FDA Committee Meeting on Testosterone
BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting
InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th
National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics
Happiest Minds & XchangeLabs Develop SiteMed® to Improve Elderly Patient Safety and Reduce Wastage of Drugs in Long Term Care Pharmacies
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer
Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology
Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients
CYRAMZA™ In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients
Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy
Latest Data Shows OrbusNeich's COMBO™ Dual Therapy Stent has Excellent Healing Benefits
Regulatory System for Medicines Can be Used More Effectively
Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis
Study Findings on Low Calorie Sweeteners, Diabetes Risk and Obesity Not Supported by Health Authorities and Other Studies, according to the Calorie Control Council
Ultrasound as effective as CT in diagnosing kidney stones without added radiation risk: AHRQ-funded study
Wellness Living Laboratory (WELL) to be First-Ever Research Study to Examine Impacts of Dietary and Lifestyle Habits on Wellness and Healthy Aging
Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable
Heart Attack Global Clinical Trials Review, H2, 2014
PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014
ZERO Taps Former DOD Research Head For Board Of Directors, Names New Vice Chair
Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study
Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C.
BioClinica to Present at 20th Annual SCDM Conference
Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery
TransCelerate BioPharma Inc. Publishes Risk-Based Monitoring Recommendations for Central Monitoring and Technology Considerations
CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies
Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System
Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit
Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin
Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma
Cardiorentis Announces Euro 45 Million Financing with HealthCare Royalty Partners to Fund Ularitide Registration Program in Acute Heart Failure
ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development
Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument
Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial
Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study
InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days
Jhpiego Announces Ebola Response Initiative

< Prev Next >
PR Newswire - United Business Media


Search Classifieds:


Copyright © , Las Vegas Business Press